We have located links that may give you full text access.
CLINICAL TRIAL
COMPARATIVE STUDY
JOURNAL ARTICLE
A possible antienuretic effect of reboxetine in children and adolescents with attention deficit/hyperactivity disorder: case series.
Neuropsychobiology 2005
UNLABELLED: Reboxetine is a selective norepinephrine reuptake inhibitor.
OBJECTIVES: To evaluate the antienuretic effect of reboxetine in children with attention deficit and mood disorders.
METHODS: Six children aged 12-15 years with primary nocturnal enuresis and with attention deficit/hyperactivity disorder with or without other comorbid disorders were treated with reboxetine (4-8 mg/day). Monitoring of enuretic frequency was recorded at baseline and once a week for 6 weeks.
RESULTS: A statistically significant decrease in bedwetting was noted along the assessment points (p < 0.001), with the maximal change noted in the first week of treatment (p = 0.004). Reboxetine was well tolerated with minimal and transient side effects.
CONCLUSIONS: reboxetine may possess an antienuretic effect in some children with the attention deficit/hyperactivity disorder.
OBJECTIVES: To evaluate the antienuretic effect of reboxetine in children with attention deficit and mood disorders.
METHODS: Six children aged 12-15 years with primary nocturnal enuresis and with attention deficit/hyperactivity disorder with or without other comorbid disorders were treated with reboxetine (4-8 mg/day). Monitoring of enuretic frequency was recorded at baseline and once a week for 6 weeks.
RESULTS: A statistically significant decrease in bedwetting was noted along the assessment points (p < 0.001), with the maximal change noted in the first week of treatment (p = 0.004). Reboxetine was well tolerated with minimal and transient side effects.
CONCLUSIONS: reboxetine may possess an antienuretic effect in some children with the attention deficit/hyperactivity disorder.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app